Scientific Industries, Inc. reported an 11% increase in sales for its Torbal Division and secured $10 million through the divestiture of the Genie Product Line. The company’s new product AI roadmap for Vivid and Bioprocessing is on target. The CEO highlighted the success of the divestiture and the upcoming launch of the VIVID line of automated pill counters. The company also shared plans for future investments in upgrading hardware and software to maintain leadership in pharmacy automation. Despite a decrease in revenue, the company gained new customer accounts and expressed optimism for future growth.

The financial results for the second quarter of 2025 showed a decrease in net revenues, primarily due to headwinds from the global trade war and cuts in government research funding. Gross profit margin decreased, and operating expenses were lower compared to the prior year. The company posted net losses for the three and six-month periods but expressed confidence in the future success of its products. A conference call will be held on August 20th to discuss these financial results. Scientific Industries continues to focus on innovation and growth in the bioprocessing and pharmacy automation industries.

Read more at GlobeNewswire: Scientific Industries Reports Financial Results for Second